Family Medicine

Long Term Follow up of Children Enrolled in the REDvent Study

Conditions:   Respiratory Distress Syndrome, Adult;   Ventilator-Induced Lung Injury;   Neurocognitive Dysfunction;   Quality of Life;   Respiration Disorders
Interventions:   Diagnostic Test: Ventilation Inhomogeneity;   Diagnostic Test: Diaphragm Ultrasound;   Diagnostic Test: Respiratory Inductance Plethysmography;   Diagnostic Test: Spirometry;   Diagnostic Test: Functional Residual Capacity;   Diagnostic Test: MIP/MEP;   Diagnostic Test: 6 minute walk test;   Diagnostic Test: Neurocognitive Testing;   Diagnostic Test: Emotional Health Assessment;   Diagnostic Test: Health Related Quality of Life;   Diagnostic Test: Functional Status;   Diagnostic Test: Respiratory Status Questionnaire
Sponsor:   Children’s Hospital Los Angeles
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

October 20, 2018 / by / in
Computer Assisted Family Intervention to Treat Self-Harm Disparities in Latinas and Sexual/Gender Minority Youth

Conditions:   Self Harm;   Depression;   Emotion Dysregulation;   Behavior Problem
Interventions:   Behavioral: Computer Assisted CIFFTA;   Behavioral: Behavioral:Traditional face-to-face treatment with no technology
Sponsors:   University of Miami;   National Institute on Minority Health and Health Disparities (NIMHD)
Not yet recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

October 19, 2018 / by / in
Treatment of FUS-Related ALS With Betamethasone – The TRANSLATE Study

Condition:   Familial Amyotrophic Lateral Sclerosis
Intervention:   Drug: Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days
Sponsor:   University of Kentucky
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

October 16, 2018 / by / in
To Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine

Condition:   Episodic Migraine
Interventions:   Drug: Atogepant 60 mg;   Drug: Standard of Care (SOC) Migraine Prevention Medication
Sponsor:   Allergan
Not yet recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

October 12, 2018 / by / in
Chaplain Family Project Trial

Conditions:   Anxiety;   PTSD;   Depression;   Communication;   Satisfaction
Intervention:   Behavioral: Spiritual Care Assessment and Intervention (SCAI) framework
Sponsors:   Indiana University;   Regenstrief Institute, Inc.;   Indiana University Health
Recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

October 11, 2018 / by / in
Multimodal Ocular Imaging in Neurodegeneration

Conditions:   Alzheimer Disease;   Alzheimer Dementia;   Frontotemporal Dementia
Interventions:   Device: Spectral-Domain Optical Coherence Tomography (SD-OCT);   Device: Magnetic Resonance Imaging (MRI);   Device: Positron Emission Tomography (PET);   Diagnostic Test: Comprehensive Ophthalmic Examination;   Device: Fundus Photography
Sponsor:   University of Michigan
Not yet recruiting
ClinicalTrials.gov: Family_Medicine | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

October 10, 2018 / by / in